The US Food and Drug Administration (FDA) has provided details on how it intends to assign a goal date based on a facility’s readiness for inspection, which includes information for generic drug ...
To ensure the US Food and Drug Administration (FDA) accepts scientific meeting requests related to a complete response letter (CRL) related to a bioequivalence issue for a generic drug, sponsors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results